Phase 2 trail data shows Hematide increases haemoglobin & reduces blood transfusion in PRCA patients
Monday, November 09, 2009 10:00 IST Palo Alto, California
Affymax, Inc and Takeda Pharmaceutical Global Research & Development Center, Inc, announced data from a phase-2 clinical trial of Hematide showing that Hematide increased haemoglobin